Kai Tang
About
In The Last Decade
Kai Tang
43 papers receiving 1.3k citations
Hit Papers
Peers
Comparison fields: 5 of 135
- Molecular Biology 585
- Cardiology and Cardiovascular Medicine 223
- Immunology 184
- Oncology 170
- Epidemiology 151
Countries citing papers authored by Kai Tang
This map shows the geographic impact of Kai Tang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kai Tang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kai Tang more than expected).
Fields of papers citing papers by Kai Tang
This network shows the impact of papers produced by Kai Tang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kai Tang. The network helps show where Kai Tang may publish in the future.
Co-authorship network of co-authors of Kai Tang
This figure shows the co-authorship network connecting the top 25 collaborators of Kai Tang. A scholar is included among the top collaborators of Kai Tang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kai Tang. Kai Tang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 3 | |
| 3 | 0 | |
| 4 | 2 | |
| 5 | 3 | |
| 6 | 5 | |
| 7 | 10 | |
| 8 | 30 | |
| 9 | 17 | |
| 10 | 16 | |
| 11 | Indoleamine 2,3-dioxygenase 1 (IDO1) inhibitors in clinical trials for cancer immunotherapy breakdown → | 246 |
| 12 | 34 | |
| 13 | 67 | |
| 14 | 0 | |
| 15 | 5 | |
| 16 | 26 | |
| 17 | 39 | |
| 18 | 115 | |
| 19 | 48 | |
| 20 | 11 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.